Revolution Medicines to Participate in Upcoming Investor
REDWOOD CITY, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage
Globe Newswire2-02-2023, 19:02
Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure 28-03-2025, 19:00